Oramed Pharmaceuticals
ORMP
ORMP
22 hedge funds and large institutions have $5.61M invested in Oramed Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
50% less capital invested
Capital invested by funds: $11.1M → $5.61M (-$5.52M)
Holders
22
Holding in Top 10
–
Calls
$62K
Puts
$79K
Top Buyers
| 1 | +$118K | |
| 2 | +$98.6K | |
| 3 | +$94.4K | |
| 4 |
D.E. Shaw & Co
New York
|
+$70.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$45.5K |
Top Sellers
| 1 | -$260K | |
| 2 | -$126K | |
| 3 | -$24K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$16.4K |
| 5 |
Morgan Stanley
New York
|
-$9.15K |